| Basics |
Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
|
| IPO Date: |
December 24, 1981 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$217.5B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.59 | 0.86%
|
| Avg Daily Range (30 D): |
$1.03 | 0.81%
|
| Avg Daily Range (90 D): |
$1.08 | 0.83%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.63M |
| Avg Daily Volume (30 D): |
4.65M |
| Avg Daily Volume (90 D): |
4.47M |
| Trade Size |
| Avg Trade Size (Sh.): |
146 |
| Avg Trade Size (Sh.) (30 D): |
56 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Inst.Trades: |
99,245 |
| Avg Inst. Trade: |
$5.52M |
| Avg Inst. Trade (30 D): |
$14.58M |
| Avg Inst. Trade (90 D): |
$14.84M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
17 |
| Market Closing Trades |
| Avg Closing Trade: |
$51.39M |
| Avg Closing Trade (30 D): |
$146.89M |
| Avg Closing Trade (90 D): |
$139.37M |
| Avg Closing Volume: |
632.91K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$8
|
$1.02
|
$.76
|
|
Diluted EPS
|
$7.97
|
$1.01
|
$.76
|
|
Revenue
|
$ 43.11B
|
$ 11.14B
|
$ 10.36B
|
|
Gross Profit
|
$ 24.15B
|
$ 6.29B
|
$ 5.89B
|
|
Net Income / Loss
|
$ 13.98B
|
$ 1.78B
|
$ 1.33B
|
|
Operating Income / Loss
|
$ 7.52B
|
$ 2.05B
|
$ 1.69B
|
|
Cost of Revenue
|
$ 18.96B
|
$ 4.85B
|
$ 4.47B
|
|
Net Cash Flow
|
$ -64M
|
$ 368M
|
$ -1108M
|
|
PE Ratio
|
15.72
|
|
|
|
|
|
